Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Subscribe to JNMT RSS feeds

dosimetry

  • You have access
    Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
    Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa and Stephen A. Graves
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 195-202; DOI: https://doi.org/10.2967/jnmt.122.263813
  • Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
    You have access
    Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
    Caio Vinicius Oliveira, Tatiane Sabriela Cagol Camozzato, Patricia Fernanda Dorow and Jéssica Pasqueta
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 233-239; DOI: https://doi.org/10.2967/jnmt.121.263502
  • You have access
    Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods
    Aadil Adnan, Kamal Deep, Mythilli Kameswaran, Dilip Nikam, Chandrakala Shanmukaih, Ashutosh Dash, Sharmila Banerjee and Sandip Basu
    Journal of Nuclear Medicine Technology December 1, 2019, 47 (4) 292-299; DOI: https://doi.org/10.2967/jnmt.118.216754
  • You have access
    Effective Dose in Nuclear Medicine Studies and SPECT/CT: Dosimetry Survey Across Quebec Province
    Mathieu Charest and Chantal Asselin
    Journal of Nuclear Medicine Technology June 1, 2018, 46 (2) 107-113; DOI: https://doi.org/10.2967/jnmt.117.202879
  • You have access
    Determining the Minimal Required Radioactivity of 18F-FDG for Reliable Semiquantification in PET/CT Imaging: A Phantom Study
    Ming-Kai Chen, David H. Menard and David W. Cheng
    Journal of Nuclear Medicine Technology March 1, 2016, 44 (1) 26-30; DOI: https://doi.org/10.2967/jnmt.115.165258
  • You have access
    Ring Badge Position for Nuclear Medicine Technologists
    David Adcock, Eileen Harp and Daniel M. Zurosky
    Journal of Nuclear Medicine Technology March 1, 1995, 23 (1) 33-35;
SNMMI

© 2023 Journal of Nuclear Medicine Technology

Powered by HighWire